What we Do
LEGE-CC is affiliated with networks like WFCC, ECCO, EMBRC, and MIRRI and plays a strategic role in advancing blue biotechnology. Its strains have contributed to studies on cancer, antibiotics, anti-obesity treatments, biofouling prevention, cosmetics and food. Several studies demonstrated that our LEGE-CC strains have potential and effective capacity to produce a diverse array of metabolites, including toxins (e.g. microcystins, anatoxin, cylindrospermopsin and BMAA) or newly discovered molecules (Portoamides, Hierridin B and C, Bartolosides, Nocuolin A, etc). As other biological resource centers worldwide, LEGE-CC seeks to provide several services (e.g. provision of starter cultures for diverse purposes, isolation and identification of strains, cyanotoxins analysis, cryopreservation, training courses, etc.).